Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
Clinical trial NCT05039281 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05039281
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2027-12-31
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.